Effectiveness and safety of non-vitamin K direct oral anticoagulants in atrial fibrillation patients with bioprosthetic valve

Effectiveness and safety of non-vitamin K direct oral anticoagulants in atrial fibrillation patients with bioprosthetic valve

Show other versions (1)

<h4>Background</h4> Non-vitamin K direct oral anticoagulant (DOAC) is effective for prevention of embolic events in nonvalvular atrial fibrillation (AF) patients. However, the effectiveness and safety of DOAC in AF patients who have bioprosthetic heart valve (BPHV) is largely unknown. &l...

Full description

Bibliographic Details
Main Authors: Inki Moon, Tae-Hwa Go, Jang Young Kim, Dae Ryong Kang, Suk Ho Sohn, Hyun-Jung Lee, Jae-Woong Choi, Jun-Bean Park, Ho-Young Hwang, Hyung-Kwan Kim, Yong-Jin Kim, Kyung-Hwan Kim, Seung-Pyo Lee
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197068/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197068/?tool=EBI

Similar Items